Rathbones Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Sell
38,345
-16,348
-30% -$1.32M 0.01% 269
2026
Q1
$4.74M Buy
54,693
+1,947
+4% +$187K 0.02% 212
2025
Q4
$5.07M Sell
52,746
-12,766
-19% -$1.24M 0.02% 214
2025
Q3
$6.24M Buy
65,512
+6,958
+12% +$640K 0.03% 190
2025
Q2
$5.1M Buy
58,554
+50,423
+620% +$4.28M 0.02% 207
2025
Q1
$731K Buy
8,131
+2,468
+44% +$221K ﹤0.01% 359
2024
Q4
$452K Sell
5,663
-450
-7% -$39K ﹤0.01% 426
2024
Q3
$550K Hold
6,113
﹤0.01% 404
2024
Q2
$481K Sell
6,113
-10,100
-62% -$828K ﹤0.01% 420
2024
Q1
$1.41M Sell
16,213
-3,613
-18% -$308K 0.01% 290
2023
Q4
$1.63M Sell
19,826
-5,098
-20% -$389K 0.01% 272
2023
Q3
$1.95M Buy
24,924
+877
+4% +$73.4K 0.01% 257
2023
Q2
$2.12M Sell
24,047
-1,060
-4% -$91.3K 0.02% 199
2023
Q1
$2.02M Sell
25,107
-3,360
-12% -$274K 0.02% 204
2022
Q4
$2.21M Sell
28,467
-875
-3% -$70.9K 0.02% 198
2022
Q3
$2.37M Sell
29,342
-1,052
-3% -$94.5K 0.03% 193
2022
Q2
$2.73M Buy
+30,394
New +$3.08M 0.03% 192
2015
Q1
Sell
-18,085
Closed -$1.31M 334
2014
Q4
$1.31M Buy
18,085
+7,095
+65% +$493K 0.09% 128
2014
Q3
$681K Buy
10,990
+2,200
+25% +$140K 0.05% 172
2014
Q2
$560K Hold
8,790
0.04% 196
2014
Q1
$541K Buy
+8,790
New +$512K 0.04% 188
2013
Q4
Sell
-10,260
Closed -$546K 247
2013
Q3
$546K Buy
10,260
+700
+7% +$37.7K 0.06% 164
2013
Q2
$492K Buy
+9,560
New +$473K 0.07% 154

Other funds holding MDT

Rathbones Group's MDT Position: Q2 2026 in Review

Rathbones Group reduced its Medtronic (MDT) stake by 30% in Q2 2026, selling an estimated $1.32M and leaving 38,345 shares worth $3M. The position accounts for 0.01% of the portfolio, ranked #269.

Rathbones Group first reported a position in MDT in Q2 2013 and has held it in 23 quarters since. The position peaked at $6.24M in Q3 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Rathbones Group held 38,345 shares of Medtronic worth $3M as of Q2 2026.
  • Rathbones Group sold 16,348 Medtronic shares in Q2 2026, an estimated $1.32M.
  • Medtronic made up 0.01% of Rathbones Group's portfolio in Q2 2026, its #269 holding.
  • Rathbones Group first reported a position in Medtronic in Q2 2013 and has held it in 23 quarters since.
  • Rathbones Group's Medtronic position peaked at $6.24M in Q3 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.